About US
Contact us
-
National Food and Drug Regulatory Working Conference held in BeijingThe 2012 National Food and Drug Regulatory Working Conference was held in Beijing on December 20, 2011. Li Keqiang, Vice Premier of the State Council, made important instructions for the conference. H2011/12/22
-
Glaxosmithkline in Montrose has been awarded a £1.46 million Research and Development grant from Scottish EnterpriseFinance Secretary John Swinney gave details of the investment on a tour of the Montrose facility today where he met some of the key staff who will be working on new research and development projects.T2011/12/21
-
AstraZeneca hit by further drug development disappointmentUK-based pharmaceutical firm AstraZeneca has been hit by further disappointments in its drug development efforts, announcing a $381.5m charge in the fourth quarter following poor results from two new2011/12/21
-
Fluoride supplements not found to be safe or effectiveAccording to the Cochrane Oral Health Group, fluoride supplements fail to reduce tooth decay in primary teeth, permanent teeth cavity-reduction is dubious and health risks are little studied. Further,2011/12/20
-
Drugmakers extend cut-price pneumonia vaccine deal(Reuters) - Pfizer and GlaxoSmithKline are increasing sales of cut-price pneumonia vaccine to developing countries by more than 50 percent, marking the scale-up of an international program to protect2011/12/20
-
GSK announces Huntington’s pact with University of DundeePharmaceutical major GlaxoSmithKline has signed a pact with the University of Dundee in the UKto investigate a potential treatment for Huntington's disease. The project will be based on the findings2011/12/20
-
Pfizer enters Prevenar 13 supply agreement to protect children from pneumococcal diseasePfizer Inc. (NYSE:PFE) today announced it has entered into a second supply agreement which will broaden and extend the duration of the Company's commitment to help protect millions of infants and youn2011/12/19
-
Top drug shortages by treatment categoryby George Miller and Skye Toor Doctors, pharmacists and even the U.S. Congress use terms like "unprecedented," "crisis" and "significant risk" to describe current U.S. drug shortages. "We're gettin2011/12/16
-
Germany gives final OK to AstraZeneca heart drugDec 15 (Reuters) - AstraZeneca's big new drug hope Brilique has won a final recommendation from medical evaluation authorities in Germany, where it is the first medicine from any company to be assesse2011/12/16
-
Merck CEO defends hefty research spendingBy Lewis Krauskopf (Reuters) - The chief executive of Merck & Co (MRK.N) on Tuesday defended his refusal to slash the drugmaker's $8 billion research budget and warned that global price constrain2011/12/16